Fosamprenavir (Lexiva, Telzir): Basics
- Fosamprenavir (Telzir, Lexiva) (December 14, 2012)
To read PDF, click here.
From AIDS InfoNet
- An Overview of Lexiva (Fosamprenavir, Telzir) (September 13, 2012)
From AIDSinfo
- Lexiva (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Patient Information About Lexiva (Fosamprenavir, Telzir) (PDF) (May 2011)
From ViiV Healthcare
- Lexiva (Fosamprenavir Calcium) -- Dear Health Care Professional Letter (December 3, 2009)
From U.S. Food and Drug Administration
- Labeling Update for Lexiva (Fosamprenavir) (December 21, 2007)
From U.S. Food and Drug Administration
- Lexiva (Fosamprenavir) (November 8, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- New Dosing Regimen for Lexiva Approved (October 12, 2007)
From U.S. Food and Drug Administration
- Fosamprenavir (908, Lexiva, Telzir) (August 15, 2006)
From AIDS Treatment Data Network
- Lexiva (Fosamprenavir) (May 2005)
To read PDF, click here.
From The Center for AIDS
- Drug Interactions: Fosamprenavir (August 2004)
From Project Inform
- Fosamprenavir: A New Protease Inhibitor Option (February 2004)
An interview with Jeffrey Nadler, principal investigator of the pivotal NEAT study.
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Waiting in the Wings: More New Drugs (November/December 2003)
A look at 908, TMC-125 and entry inhibitors in development.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FDA Approves Lexiva (Fosamprenavir Calcium) (October 21, 2003)
From U.S. Food and Drug Administration
- Position Paper on 908 (Fosamprenavir, Lexiva) (October 13, 2003)
To read PDF, click here.
In TAGline, from Treatment Action Group
|
Advertisement
|